Paul Pagnini, M.D.

Radiation Oncology

Locations and Appointments

Insurances Accepted

Please contact the doctor's office to verify that your insurance is accepted.

*Indicates this doctor is no longer accepting new patients with this insurance plan.

  • HMO
  • Medicare
  • PPO
  • EPO/POS
  • CHP
  • Blue Access
  • Blue Connection
  • EPO
  • HMO
  • Mediblue (Senior)
  • PPO
  • CBP
  • Medicaid
  • Medicare
  • Freedom
  • Liberty
  • Medicare Advantage
  • Metro/Core/Charter
  • Community Plan
  • Medicare
  • HMO
  • Medicare
Personal Statement

I am a board-certified radiation oncologist working in clinical medicine with an interest in clinical trials and improving the quality of life for people with cancer.

I specialize in caring for people with cancer with a specific focus on hematologic malignancies (lymphoma, leukemia, multiple myeloma)  genitourinary malignancies (prostate, bladder, kidney) and central nervous system ( brain, spine) tumors, both benign and malignant. I  strive to embrace each patient’s needs both medically and emotionally. My goal is to deliver compassionate care,  using state of the art radiotherapy in a multidisciplinary setting. I truly enjoy taking time with my patients and their families so they fully understand their diagnosis and our treatment recommendations.

I have a special interest in utilizing cutting-edge technology, such as Image Guided Radiotherapy (IGRT), Adaptive Radiotherapy (ART), Stereotactic Radiosurgery (SRS) and Stereotactic Body Radiotherapy (SBRT) in order to minimize treatment related toxicity.

Biographical Info

Dr. Paul Pagnini has served as a leader in community-based and academic radiation oncology for the past 20 years. Dr. Pagnini completed his residency training in Radiation Oncology at Tufts/New England Medical Center where he was chief resident in his final year. He was awarded the prestigious Research Fellowship Award from the American Society of Therapeutic Radiation Oncology, which enabled him to study the role of intensity modulated radiation therapy (IMRT) for the treatment of cancers of the central nervous system. He has served on the Faculty of the University of Southern California, Keck School of Medicine where he was the Radiation Oncology Residency Program Director. His most recent position was with the Cleveland Clinic Florida, where he served as Department Chair for the last five years. He has multiple peer reviewed publications in the areas of intensity modulated radiation therapy (IMRT), 3-D conformal radiation therapy, Cyberknife, and Gamma-Knife radiosurgery.

Honors and Awards
  1. Fuller Junior Research Fellowship Award, The American Cancer Society, 1986
  2. Lambda Epsilon Sigma Honor Society Award, Stonehill College, 1987
  3. Sigma Zeta, National Collegiate Honor Society, 1988
  4. Research Fellowship Award, American Society for Therapeutic Radiation Oncology, 1999
  5. USC Faculty Teaching Award, Radiation Oncology, University of Southern California. Keck School of Medicine, 2011
Board Certifications
American Board of Radiology
National Board of Medical Examiners
Clinical Expertise
Palliative Care
Gamma Knife Radiosurgery
Lymphoma
Leukemia
Multiple Myeloma
Cancer of Prostate
Bladder Cancer
Brain Tumors
Spinal Cord Tumor
Malignant Tumor of Spinal Cord
Benign Tumor of Spinal Cord
Benign Brain Tumor
Stereotactic Radiosurgery
Languages
English
Education 
  • M.D.
    Tufts University School of Medicine
    1992
  • B.S.
    Stonehill College
    1988
Appointments 
  • Associate Attending Radiation Oncologist
    NewYork-Presbyterian Hospital
  • Associate Professor of Clinical Radiation Oncology (Pending Appointment at Rank)
    Weill Cornell Medical College, Cornell University

Relationships and collaborations with for-profit and not-for profit organizations are of vital importance to our faculty because these exchanges of scientific information foster innovation. As experts in their fields, WCM physicians and scientists are sought after by many organizations to consult and educate. WCM and its faculty make this information available to the public, thus creating a transparent environment.

No External Relationships Reported